Panbela Therapeutics Inc Stock Ownership - Who owns Panbela Therapeutics?

Insider buying vs selling

Have Panbela Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when PBLA insiders and whales buy or sell their stock.

PBLA Shareholders

What type of owners hold Panbela Therapeutics Inc stock?
Michael T. Cullen3.49%586,387$211.10kInsider
Donald Robert Schemel3.45%579,273$208.54kInsider
Sabby Management LLC2.54%426,363$153.49kInstitution
Cvi Holdings LLC2.35%394,901$142.16kInstitution
Jeffrey E. Jacob2.19%367,076$132.15kInsider
Hudson Bay Capital Management LP2.11%355,000$127.80kInstitution
Altium Capital Management LP2.00%335,324$120.72kInstitution
Daniel Donovan1.85%310,319$111.71kInsider
Paul W. Schaffer1.18%197,336$71.04kInsider
Anson Funds Management LP0.97%163,024$58.69kInstitution

1 of 3

PBLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ONCR40.62%59.38%Net Selling

Panbela Therapeutics Stock Ownership FAQ

Who owns Panbela Therapeutics?

Panbela Therapeutics (NASDAQ: PBLA) is owned by 11.56% institutional shareholders, 12.70% Panbela Therapeutics insiders, and 75.74% retail investors. Michael T. Cullen is the largest individual Panbela Therapeutics shareholder, owning 586,387.00 shares representing 3.49% of the company. Michael T. Cullen's Panbela Therapeutics shares are currently valued at $197.03k.

If you're new to stock investing, here's how to buy Panbela Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.